Bellefleur has been acquired by Domidep
Belgian nursing home Bellefleur has been sold to Domidep, one of France’s largest private nursing home operators.
Headquartered in Aubange, Belgium, Bellefleur owns and operates a state-of-the-art nursing home in the Luxembourg province. After the nursing home’s refurbishment and extension in 2022, Bellefleur operates 91 accredited beds, with a total capacity for 99 beds. Through its strategic location, a limited competitive landscape in the region and efficient management, Bellefleur has been able to achieve an occupancy rate of around 100% for long-term stays since 2022.
Founded in 1989, Domidep is a leading player in the healthcare sector, operating mainly medicalized nursing homes. On the strength of its roots and experience in France, with almost 120 establishments at the end of 2022 accommodating 7,700 residents, Domidep is now also expanding internationally. The company is already present in Germany and Belgium, with over 35 establishments for almost 2,900 residents.
Oaklins’ team in Belgium acted as the exclusive M&A sell-side advisor to Bellefleur in this transaction.
Falar com a equipa da transação
Transações relacionadas
Afric Phar has been acquired by Pharma Capital
Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.
Saber maisXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Saber maisBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Saber mais